Compositions for delivery of insoluble agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8877746
SERIAL NO

13391440

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and methods of making the same for in vivo delivery of lixivaptan to a subject in need thereof are described. The composition includes a substantially water-insoluble pharmacologically active agent (e.g., lixivaptan) and a substantially water-insoluble matrix forming material (e.g., a Vitamin E semi-ester), wherein the pharmacologically active agent is dispersed in said matrix forming material, and wherein the composition delivers said substantially water-insoluble pharmacologically active agent upon exposure to physiological medium.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTESSA BIOSCIENCES INC1 FEDERAL STREET 38TH FLOOR BOSTON MA 02110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abu-Izza, Khawla Woburn, US 4 28
Chen, Andrew Xian San Diego, US 47 690
Chen, Hailiang San Diego, US 25 156
Frech, Patricia Horgen, CH 5 8
Schmidt, Christoph Lausanne, CH 106 1207

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 4, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00